Inflammatory activation and cholinergic anti-inflammatory system in eating disorders

Brain, Behavior, and Immunity

Volumn 32, Issue , 2013, Pages 33-39

  MacDowell, Karina S ^a,b,d   Díaz Marsá, Marina ^a,b,c   Güemes, Itziar ^a,b,c   Rodríguez, Alberto ^a,b,c   Leza, Juan Carlos ^a,b,d   Carrasco, José Luis ^a,b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Biomarker; Cholinergic receptor; Eating disorders; Inflammatory antiinflammatory balance

Indexed keywords

BIOLOGICAL MARKER; BUNGAROTOXIN RECEPTOR; COTININE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; EATING DISORDER; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; OPEN STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PILOT STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 84891371061     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.04.006     Document Type: Article

References (48)

1. Adler, L.E., Olincy, A., Waldo, M., Harris, J.G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., Freedman, R., 1998. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24, 189-202.
2. Ahren-Moonga, J., Lekander, M., von, B.N., Ronnelid, J., Holmgren, S., af, K.B., 2011. Levels of tumour necrosis factor-alpha and interleukin-6 in severely ill patients with eating disorders. Neuropsychobiology 63, 8-14.
3. Altavilla, D., Guarini, S., Bitto, A., Mioni, C., Giuliani, D., Bigiani, A., Squadrito, G., Minutoli, L., Venuti, F.S., Messineo, F., De, M.V., Bazzani, C., Squadrito, F., 2006. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock 25, 500-506.
4. American Psychiatric Association, 2000. Diagnostic Criteria from DSM-IV-TR. American Psychiatric Association, Washington, DC.
5. Basurte, E., Díaz-Marsa, M., Martin, O., Carrasco, J.L., 2004. Traumatic childhood background, impulsiveness and hypothalamus-pituitary-adrenal axis dysfunction in eating disorders. A pilot study. Actas Esp. Psiquiatr. 32, 149-152.
6. Benowitz, N.L., Dains, K.M., Dempsey, D., Herrera, B., Yu, L., Jacob III, P., 2009. Urine nicotine metabolite concentrations in relation to plasma cotinine during lowlevel nicotine exposure. Nicotine Tob. Res. 11, 954-960.
7. Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P.M., Petrov, D., Ferstl, R., von, E.M., Wendt, T., Rudofsky, G., Joswig, M., Morcos, M., Schwaninger, M., McEwen, B., Kirschbaum, C., Nawroth, P.P., 2003. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. USA 100, 1920-1925.
8. Bradford, M., 1976. Rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
9. Brambilla, F., 2001. Social Stress in Anorexia Nervosa. A review of immunoendocrine relationships. Physiol. Behav. 73, 365-369.
10. Brambilla, F., Bellodi, L., Brunetta, M., Perna, G., 1998. Plasma concentrations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in anorexia and bulimia nervosa. Psychoneuroendocrinology 23, 439-447.
11. Bruce, K.R., Steiger, H., Israel, M., Groleau, P., Ng, Y.K., Ouellette, A.S., Sycz, L., Badawi, G., 2012. Cortisol responses on the dexamethasone suppression test among women with Bulimia-spectrum eating disorders: associations with clinical symptoms. Prog. Neuropsychopharmacol. Biol. Psychiatry 38, 241-246.
12. Cooper, P., Taylor, M., Cooper, Z., 1987. The development and validation of the body shape questionnaire. Int. J. Eat. Disord. 6, 485-494.
13. Corcos, M., Guilbaud, O., Paterniti, S., Moussa, M., Chambry, J., Chaouat, G., Consoli, S.M., Jeammet, P., 2003. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 28, 229-249.
14. Crisp, A.H., 1978. Disturbances of neurotransmitter metabolism in anorexia nervosa. Proc. Nutr. Soc. 37, 201-209.
15. Dalack, G.W., Becks, L., Hill, E., Pomerleau, O.F., Meador-Woodruff, J.H., 1999. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology 21, 195-202.
16. Dantzer, R., 2004. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 500, 399-411.
17. de Jonge, W.J., Ulloa, L., 2007. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151, 915-929.
18. Digby, G.J., Noetzel, M.J., Bubser, M., Utley, T.J., Walker, A.G., Byun, N.E., Lebois, E.P., Xiang, Z., Sheffler, D.J., Cho, H.P., Davis, A.A., Nemirovsky, N.E., Mennenga, S.E., Camp, B.W., Bimonte-Nelson, H.A., Bode, J., Italiano, K., Morrison, R., Daniels, J.S., Niswender, C.M., Olive, M.F., Lindsley, C.W., Jones, C.K., Conn, P.J., 2012. Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models. J. Neurosci. 32, 8532-8544.
19. Emeric Sauval, E., Polack, E., Bello, M., Guitelman, A., Finkielman, S., Nahmod, V., Guitelma, N., Artz, E., 1989. Anorexia nerviosa y bulimia nerviosa un modelo para el estudio de las interacciones inmmuno-endocrinas en respuesta al CRH humano. Rev. Argent. Endocrinol. Metab. 26, 73.
20. Gallowitsch-Puerta, M., Pavlov, V.A., 2007. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci. 80, 2325-2329.
21. Gallowitsch-Puerta, M., Tracey, K.J., 2005. Immunologic role of the cholinergic antiinflammatory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann. NY Acad. Sci. 1062, 209-219.
22. García-Bueno, B., Caso, J.R., Leza, J.C., 2008. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci. Biobehav. Rev. 32, 1136-1151.
23. Garner, D.M., Olmsted, M.P., Polivy, J., 1983. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int. J. Eat. Disord. 2, 15-34.
24. Glassman, A.H., Covey, L.S., 1990. Future trends in the pharmacological treatment of smoking cessation. Drugs 40, 1-5.
25. Gotti, C., Fornasari, D., Clementi, F., 1997. Human neuronal nicotinic receptors. Prog. Neurobiol. 53, 199-237.
26. Greeman, M., McClellan, T.A., 1991. Negative effects of a smoking ban on an inpatient psychiatry service. Hosp. Community Psychiatry 42, 408-412.
27. Henderson, M., Freeman, C., 1987. A self-rating scale for bulimia. The «BITE». Br. J. Psychiatry 150, 18-24.
28. Kahl, K.G., Kruse, N., Rieckmann, P., Schmidt, M.H., 2004. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychoneuroendocrinology 29, 13-20.
29. Leibowitz, S.F., 1987. Hypothalamic neurotransmitters in relation to normal and disturbed eating patterns. Ann. NY Acad. Sci. 499, 137-143.
30. Leonard, S., Adler, L.E., Benhammou, K., Berger, R., Breese, C.R., Drebing, C., Gault, J., Lee, M.J., Logel, J., Olincy, A., Ross, R.G., Stevens, K., Sullivan, B., Vianzon, R., Virnich, D.E., Waldo, M., Walton, K., Freedman, R., 2001. Smoking and mental illness. Pharmacol. Biochem. Behav. 70, 561-570.
31. Leonard, S., Mexal, S., Freedman, R., 2007. Smoking, genetics and schizophrenia: evidence for self medication. J. Dual Diagn. 1, 43-59.
32. Lucas, S.M., Rothwell, N.J., Gibson, R.M., 2006. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (Suppl 1), 232-S240.
33. Mitchel, J., Eckert, E., Pomeroy, C., 1994. The role of cytokine in anorexia nervosa. Neuropsychopharmacology 10, 2065.
34. Monteleone, P., Maes, M., Fabrazzo, M., Tortorella, A., Lin, A., Bosmans, E., Kenis, G., Maj, M., 1999. Immunoendocrine findings in patients with eating disorders. Neuropsychobiology 40, 115-120.
35. Nakai, Y., Hamagaki, S., Takagi, R., Taniguchi, A., Kurimoto, F., 1999. Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptor in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 84, 1226-1228.
36. Nizri, E., Irony-Tur-Sinai, M., Lory, O., Orr-Urtreger, A., Lavi, E., Brenner, T., 2009. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J. Immunol. 183, 6681-6688.
37. Nova, E., Gomez-Martinez, S., Morande, G., Marcos, A., 2002. Cytokine production by blood mononuclear cells from in-patients with anorexia nervosa. Br. J. Nutr. 88, 183-188.
38. Picciotto, M.R., Brunzell, D.H., Caldarone, B.J., 2002. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13, 1097-1106.
39. Polack, E., Nahanod, V., Emeric Sauval, E., Bello, M., Costas, M., Finkielman, S., Artz, E., 1993. Low lymphocyte interferon-gamma production and variable proliferative response in anorexia nervosa patients. J. Clin. Immunol. 136, 445-451.
40. Pomeroy, C., Eckert, E., Hu, S., Eiken, B., Mentink, M., Crosby, R.D., Chao, C.C., 1994. Role of interleukin-6 and transforming growth factor-beta in anorexia nervosa. Biol. Psychiatry 36, 836-839.
41. Raymond, N.C., Dysken, M., Bettin, K., Eckert, E.D., Crow, S.J., Markus, K., Pomeroy, C., 2000. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int. J. Eat. Disord. 28, 293-302.
42. Ribases, M., Fernández-Aranda, F., Gratacos, M., Mercader, J.M., Casasnovas, C., Nuñez, A., Vallejo, J., Estivill, X., 2008. Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. J. Psychiatr. Res. 42, 50-57.
43. Sauriyal, D.S., Jaggi, A.S., Singh, N., 2011. Extending pharmacological spectrum of opioids beyond analgesia: multifunctional aspects in different pathophysiological states. Neuropeptides 45, 175-188.
44. Schattner, A., Steinbock, M., Tepper, R., Schonfeld, A., Vaisman, N., Hahn, T., 1990a. Tumour necrosis factor production and cell-mediated immunity in anorexia nervosa. Clin. Exp. Immunol. 79, 62-66.
45. Schattner, A., Tepper, R., Steinbock, M., Hahn, T., Schoenfeld, A., 1990b. TNF, interferon-gamma and cell-mediated cytotoxicity in anorexia nervosa; effect of refeeding. J. Clin. Lab. Immunol. 32, 183-184.
46. Scherag, S., Hebebrand, J., Hinney, A., 2010. Eating disorders: the current status of molecular genetic research. Eur. Child Adolesc. Psychiatry 19, 211-226.
47. Schreiber, E., Matthias, P., Muller, M.M., Schaffner, W., 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
48. Silva, J.R., 2011. Restraint eating and sensitivity to stress: preliminary experimental evidence. Riv. Psichiatr. 46, 300-304.